| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |